| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Institut TransMedTech de Montréal [Automatic translation follows] Next-generation medical technologies development / développement de technologies médicale de lendemains générations The TransMedTech Institute's mission is to: - support innovation in health technologies that meet the needs of the community, in order to facilitate and catalyze their development and implementation; - train the next generation of leaders in the field of medical technologies and support the industry and the innovation community; - mobilize knowledge and animate a vibrant and dynamic environment that fosters innovation and the adoption of solutions. The Living Lab approach accelerates the development, validation and transfer processes in the health system. Medical technologies, … Type: | 13 | 3 | 9 | 30 |
 | Milestone Pharmaceuticals, Inc. Headquartered in Montreal, with a growing subsidiary in Charlotte, NC Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by … Type: | 1 | 1 | 1 | 45 |
 | Kara Connect A proactive mental health and wellbeing solution for employees, to reduce burnout, absenteeism and attrition. Kara Connect provides a bespoke Wellbeing Hub for your workplace, giving your team members rapid, direct access to the professional support of their choice. Providing handpicked experts across 58 specialist areas from mental health to menopause, from fertility to finances, from career to conflict, in over 24 languages. With Kara Connect your employees and their families have direct access to CHOOSE the health care professional or expertise they require. All this prevents burnout and builds loyalty in your team, and frees up your managers to … Type: | 5 | 2 | 1 | 41 |
 | Walk With Path Limited Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. 🏔 Explore beyond possible. 🦿 Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. Product design, Medical devices, Innovation design engineering, Innovation, Parkinson's, Diabetes, Gait disorders, Data science, and Remote monitoring Type: | 16 | 6 | 12 | 14 |
 |  LEO Innovation Lab - LEO Ventures A/S Innovating to improve the lives of people living with chronic skin conditions LEO Innovation Lab is an independent unit, established by LEO Pharma as part of a long-term strategic decision to focus on patient needs. We nurture companies to lead the digital health revolution with the single goal of improving the quality of life for people living with chronic skin conditions. Located in Copenhagen, with hubs around the globe, the Innovation Lab creates companies and invests in ventures with disruptive potential in the healthcare arena. healthcare, psoriasis, ehealth, technology, skin conditions, patient-centric, artificial intelligence, health technology, machine learning, clinical trials, … Type: | 9 | 2 | 2 | 7 |
 | Kaffe Bueno Unlocking Coffee's Health Potential since 2016. Upcycling Coffee Into Bioactive & Functional Ingredients. Established in 2016, Kaffe Bueno is the first company to ever fully breakdown and valorise spent coffee grounds into active and functional ingredients for personal care, advanced materials, animal and human nutrition. Through cutting-edge technology and patented applications of the unique coffee molecules, Kaffe Bueno is the pioneer and leader of the coffee upcycling movement. Our mission is to unlock coffee's health potential where harmful emissions are minimised and coffee’s by-product usability is maximised. By extending coffee's economical life, we will be able to give back to … Type: | 8 | 4 | 7 | 30 |
 | ACS Biotech [Automatic translation follows] Cartilage Repair Solution ACS Biotech Develops Innovative Injectable Cartilage Repair Solution for Reliable and Long-Lasting Cartilage Repair to Treat Cartilage Injuries Type: | 17 | 6 | 9 | 6 |
 | Quantificare QuantifiCare is a fast growing leading Imaging CRO offering: - Pre-clinical to phase IV clinical trial services across a wide range of clinical areas to pharmaceutical, biotech and cosmetic industries. - Innovative imaging tools tailored for medical specialists including plastic surgeons, aesthetic specialists and dermatologists. Type: | 1 | 1 | 0 | 135 |
 | Ocean Diagnostics Inc. Diagnosing and protecting the health of our own oceans and waterways from microplastic pollution and biodiversity loss. Ocean Diagnostics is an environmental impact company that develops innovative technology to empower researchers and community scientists to collect and analyze the microplastics and environmental DNA data needed to inform decision making. Together, we help to protect our planet from plastic pollution and biodiversity loss. microplastics, environmental DNA (eDNA), Marine pollution, community science and education, environmental science, educator resources, biodiversity monitoring, and ocean technology Type: | 0 | 0 | 0 | 14 |
 |  Laverock Therapeutics Programmable gene silencing to transform advanced therapies Next generation programmable cell therapies Type: | 2 | 0 | 2 | 37 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 20 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 8 |
 | Entero Therapeutics (Nasdaq: ENTO) A biopharma company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases Entero Therapeutics, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company’s programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. For more … Type: | 2 | 0 | 2 | 13 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 1 | 1 | 6 |
 | Green City Solutions GmbH We grow fresh air! #CityTree #CityBreeze #WallBreeze 🍃 We grow fresh air - with moss, naturally. More than half of humanity lives in cities – and the trend is rising. Cities are clearly the living space of the future. And yet our most important resource, the air we breathe, is in many places so polluted that breathing is harming our health. In the future we have in mind, fresh air in urban areas is available to everyone. That’s why we developed the world’s first regenerative bio-tech filters for verifiable improvements in air quality. #WeGrowFreshAir with CityTree, CityBreeze and WallBreeze. Moos, … Type: | 41 | 4 | 35 | 33 |
 | Nanoscribe Make small things matter. In 2007, a team of researchers from Karlsruhe Institute of Technology (KIT) set out to rethink microfabrication. At that time, Two-Photon Polymerization (2PP), the underlying core physics and chemistry for the Nanoscribe technology, was a small niche research topic. The founders however recognized the potential and made 2PP-based 3D printers commercially available. Besides the 2PP-based 3D Microfabrication technology, Nanoscribe revealed its proprietary Two-Photon Grayscale Lithography (2GL ®) with presenting the maskless lithography platform Quantum X in 2019. 2GL combines 2PP with the qualities of grayscale lithography and thus enables rapid and precise microfabrication of ultra-smooth surfaces … Type: | 5 | 0 | 3 | 75 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 1 | 1 | 0 | 6 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 2 | 1 | 1 | 17 |
 | Life Supporting Technologies Innovation comming to life Life Supporting Technologies (LifeSTech) is a research, development and innovation group, located within the Universidad Politecnica de Madrid (UPM) and dedicated to design, development and evaluation of services and applications based on ICT, to create and promote new ideas, methods and technological solutions to improve people's lives. e-Learning, e-Inclusion, and e-Government | 4 | 1 | 3 | 25 |
 | Veracyte, Inc. High-value insights, high-impact decisions Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. | 6 | 3 | 1 | 588 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 21 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 275 |
 | BioVersys AG Leadership in overcoming the antibiotic resistance crisis. BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment options in the antimicrobial and microbiome fields. By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our … | 1 | 0 | 1 | 27 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 43 |
 | MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company. Conditioning the gut ecosystem for disease prevention and therapy. Spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, aimed at shaping the intestinal microbiota for the cure and prevention of diseases such as bowel diseases and cancer. The gut ecosystem conditions the function of all our organs and plays a fundamental role in our wellbeing. The mucosal immune system has co-evolved with the intestinal microbiota to adapt its function to a number of environmental and possibly pathogenic factors. MV Bio leverages a microbiota-mediated mechanism regulating the physiological response of the intestinal … Type: | 1 | 1 | 0 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 10 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 1 | 1 | 0 | 24 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 3 | 2 | 0 | 17 |
 | LDMH Partners Life Sciences Advisors. UK | EU | North America We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 0 | 0 | 7 |
 | Crafting Future Wir produzieren nachhaltige Mehrwegbehälter und entwickeln gemeinsam die für dich passende Mehrweglösung Disposable waste is one of the biggest problems of our time. At the same time we know that there will never be a world without plastics. That is why we have made it our mission to question the plastics industry. In our material selection, product design and product development, we place a special focus on the end of a product's life cycle. In doing so, we consider the recovery of an equivalent amount of plastic compared to the amount used in manufacturing. We develop our own reusable products … Type: | 4 | 0 | 4 | 10 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 1 | 0 | 1 | 11 |
 | Oculyze One of the leading platforms for cloud based quantitative image recognition. Using machine learning and Artificial Intelligence Oculyze has transferred the computer vision software for lab equipment from the table top to the cloud. To prove this revolutionary approach works and is market ready, Oculyze launched the yeast cell counters for breweries and wineries. This device works using a microscope connected to a smartphone and the Oculyze app to upload the images to the cloud where they are analysed by image recognition algorithms. These combine methodical pattern recognition with artificial intelligence and deep learning to offer quantitative real-time image analysis. … Type: | 3 | 2 | 1 | 7 |
 | Plateforme d'ingénierie matériaux et surfaces (PIMS) [Automatic translation follows] Supported by Centrale Lille, the University of Lille and the CNRS ▶ The Materials and Surfaces Engineering Platform (PIMS) is the platform for the development and characterization of materials at Centrale Lille and the University of Lille. It has 3 centers: • Center 1: Development of materials by conventional processes • Center 2: Development by additive manufacturing • Center 3: Characterization of their microstructures and material properties 🔎 Research within PIMS focuses on understanding the process - microstructure - properties relationship in different research fields (transport, health and energy). 💡The platform has the capacity to develop metals … Type: | 2 | 0 | 2 | N/A |
 | Landmark BioVentures AG Integrated and agile biotech hub-and-spoke company Landmark BioVentures AG (LBV), founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company. LBV takes a unique model focused on lean operations, smart capital allocation, and diversified yet complementary nexus of seven companies developing 10 first in class therapeutics. drug development , biotech, oncology, immuno-oncology, ophthalmology, immunology, pathobiology, inflammation, and business development Type: | 5 | 1 | 5 | 4 |
 | National Brain Tumor Society Conquering and curing brain tumors—once and for all National Brain Tumor Society invests in, mobilizes, and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and care partners. We are the largest patient advocacy non-profit solely dedicated to the brain tumor community and a leading thought leader in the neuro-oncology field. Headquartered in Newton, Massachusetts, our organization raises funds to invest in accelerating brain tumor treatments, prepare the community to navigate their unique brain tumor experience, and convene stakeholders while changing public policy to improve the lives and survival of brain tumor patients. … Type: | 1 | 0 | 0 | 79 |
 | Neurentis plc NEW FRONTIERS IN NEUROSCIENCE Expertise, Experience, Innovation, Vision, Values. Neurentis PLC is a late-clinical stage UK biotech company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with 3 products: 1) an advanced lead drug candidate, a prescription pharmaceutical (selegiline), in a transdermal patch, for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development, 2) a small molecule agonist of the oxytocin receptors for the treatment of Autism, Chronic and Neuropathic Pain and addiction to alcohol and opioids and 3) … Type: | 1 | 1 | 0 | 3 |
 | EURIdoc PhD Programme The Eucor - Upper Rhine Immunology doctoral research programme is coordinated by Eucor partner universities EURIdoc is a new interdisciplinary doctoral programme in immunology in the Upper Rhine region coordinated by Eucor - The European Campus. The programme builds on the excellent research undertaken by immunologists at research institutions in the region and long-standing cooperation among them. It will contribute to strengthening the research effort in personalised health – precision medicine. EURIdoc receives funding from the EU through the MSCA-COFUND (Horizon 2020) scheme. EURIdoc could attract 28 talented young researchers from around the world with diverse academic backgrounds. From January … Type: | 1 | 0 | 0 | 2 |
 | Aiforia Technologies Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis. Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis, across a variety of fields from oncology to neuroscience and more. From empowering researchers in the identification of novel biomarkers of disease, and supporting R&D scientists in speeding up time-to-market of novel drugs, to helping pathologists enhance the accuracy of cancer diagnostics — … Type: | 0 | 0 | 0 | 87 |
 | IDDI - Regulatory Statistics & Clinical Data Science Experts Proven scientific and data quality excellence ensuring your clinical trial submissions IDDI is a therapy-focused expert regulatory statistics, clinical data services and high-level strategic consulting contract research organization committed to increasing efficiency and mitigating risks throughout the drug development process. For over 30 years, we have provided agile clinical trial services for pharmaceutical, biotechnology, and medical device/diagnostic companies to ensure their clinical data is ready for submission. With a deep expertise in advanced biostatistics and study design, we also offer regulatory, statistical and clinical consultancy, comprehensive data management services and integrated RTSM-EDC for the successful execution of your clinical development … Type: | 1 | 0 | 0 | 182 |
 | iLoF Using AI and Photonics to enable a new era of personalized, precision medicine. iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported … Type: | 27 | 4 | 21 | 36 |
 | IceCure Medical The Choice of Cryoablation IceCure Medical is a medical device company dedicated to providing patients and healthcare providers with the minimally invasive choice of cryoablation using liquid nitrogen for the treatment of benign and cancerous tumors. Our flagship device, the ProSense System, utilizes the power of liquid nitrogen to generate ultra-cold temperatures quickly to create large lethal zones that freeze and destroy tumors. By using liquid nitrogen, the system enables procedures to be performed in office-based settings, as there is no need for special safety precautions compared to other high-pressure gases used in cryoablation such as argon. In 2024, IceCure … Type: | 0 | 0 | 0 | 71 |
 | ObsEva SA ObsEva. Nature meets Nurture Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. Type: | 0 | 0 | 0 | 11 |
 | Silence Therapeutics plc Precision Engineered Medicines to Silence Diseases Our 20-plus years of RNAi experience together with our validated mRNAi GOLDTM platform make us a partner of choice for pharmaceutical companies looking to access the benefits of the siRNA and add this revolutionary modality to their discovery pipeline. As pioneers in the design and development of siRNAs (short interfering RNAs), Silence Therapeutics is advancing a new generation of medicines to potentially address the needs of patients who have limited or inadequate treatment options. Our mission is to use our technology to create a new generation of therapeutics which can improve outcomes for patients … Type: | 0 | 0 | 0 | 108 |
 | BioNTech IMFS BioNTech Innovative Manufacturing Services (IMFS) is a subsidary of BioNTech SE. We are specialized in the development and production of innovative products (viral vectors, cells and ivt mRNA). Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facilities. We offer contract services for retroviral vector manufacturing for clinical supply. The company has more than 500 experienced and highly skilled employees and is always looking for motivated people! See also www.biontech-imfs.de Cell therapy, GMP manufacturing, Gene Therapy, RNA manufacturing, Retroviral vector manufacturing, Contract Manufacturing, … Type: | 0 | 0 | 0 | 251 |
 | Cibus A leading agricultural biotech company using non-GMO precision gene-editing technology to reshape crop protection. Overview: Cibus is part of the multi-billion-dollar plant seed industry. Cibus leads the new era of high throughput gene editing technology that can develop plant traits precisely at a fraction of the time and cost of conventional breeding. Cibus is not a seed company. We are a technology company that uses gene editing to develop plant traits. Cibus licenses its traits to seed companies for royalties on seeds that use its traits. Cibus’ target market is Productivity Traits” that improve yields, lower input costs such as … Type: | 3 | 0 | 3 | 212 |
 | BioSTL Driving St. Louis Innovation through startups | capital | people | place | policy | global connectedness Since 2001, St. Louis nonprofit BioSTL has laid the foundation for the region's innovation economy with a comprehensive set of transformational programs that advance St. Louis’ leadership in solving important world challenges in agriculture, medicine, healthcare, and other technology areas. BioSTL has introduced nationally-acclaimed initiatives in startup creation and investment (BioGenerator), strategic business attraction (GlobalSTL), physical environment (including the Cortex Innovation District and BioGenerator Labs), entrepreneur support, seed and venture capital, a diverse and inclusive workforce, and public policy. Vision: St. Louis will … Type: | 10 | 5 | 4 | 34 |
 | Alzforum Alzforum, founded in 1996, is a free, dynamic, web-based scientific community dedicated to understanding Alzheimer's disease and related disorders. Our editorial priorities are as diverse as the needs of the research community. The website reports news on the latest scientific findings from basic research to clinical trials; maintains public databases of animal models, therapeutics, genetic risk factors, and biomarkers; and holds live discussion forums to promote debate, speed the dissemination of new ideas, and break down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer's disease. The Alzforum team of professional science writers and … Type: | 0 | 0 | 0 | 11 |
 | Seelos Therapeutics, Inc. A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare diseases. Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL". Rare Diseases, Parkinson's Disease, Sanfilippo Syndrome, Suicidality, Depression, PTSD, MDD, CNS Disorders, … Type: | 2 | 0 | 1 | 12 |
 | Bio4Comp – Parallel Network-Based Biocomputation Enabling future biocomputers Biocomputers are expected to be the future of computing, potentially being more economical and energy efficient. We are one of the international initiatives working to make it a reality. The idea behind Bio4Comp, an EU-funded research project, is that biomolecular machines, each only a few billionth of a meter (nanometers) in size, can solve problems by moving through a nanofabricated network of channels designed to represent a mathematical algorithm. We call our approach "network-based biocomputation". Whenever the biomolecules reach a junction in the network, they either add a number to the sum they are calculating or leave … Type: | 0 | 0 | 0 | 3 |
 | Phynova Group Ltd We believe in turning the power of plants into solutions that restore and maintain the balance in human health Phynova is a British life science company specialised in developing and commercialising unique, science proven health ingredients, powered by plants. Next to a number of pipeline ingredients, Phynova’s key ingredient is Reducose®, a patented water extract of white mulberry leaves. Through 10+ clinical studies it has been shown to promote healthy blood glucose and insulin responses and Reducose® is now being used by Dietary Supplement and F&B brands globally. Plant based compounds, Nutraceuticals, Functional ingredients, Blood Glucose Management, and Joint and … Type: | 2 | 0 | 1 | 16 |
 | Cerule International Building Extraordinary Lives® with proven, cutting-edge dietary supplements and skin care products. Cerule® is a biotech company that sells proven, one of a kind dietary supplements, skin care and wellness products. Our products are validated by years of scientific research and development, patents and published scientific papers. We challenge the status quo and are constantly striving to find and develop groundbreaking health solutions that produce positive changes to help you live a longer, healthier and happier life. It is with this mission that Cerule has been positively impacting countless lives worldwide for more than a decade. We believe the extraordinary … Type: | 0 | 0 | 0 | 114 |
 | BIOSENIC S.A. New solutions for autoimmune, inflammatory and bone diseases. BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair. Cell therapy, Bone and joint tissue regeneration, Osteo-Articular Diseases, autoimmunity, immunity, autoimmune disease, and arsenic Type: | 16 | 4 | 11 | 26 |
 | ISI Foundation Pursuing the best science possible in an environment without constraints. The ISI Foundation is a private, non-profit research center established in 1983 in Turin, Italy. Its primary focus is scientific research and advanced education in the fields of data science, complex systems, and the applications of data and computational models to social impact and public health. Combining local relevance with global influence, ISI Foundation fosters an interdisciplinary scientific culture and strives to support the next generation of scientists in tackling the complex challenges of our era. Over the course of four decades, ISI Foundation has created a network of renowned … Type: | 5 | 1 | 0 | 48 |
 | ITM Isotope Technologies Munich SE Dedicated to giving cancer patients better answers than "maybe". PASSION FOR PRECISION. ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radioisotopes and generator platform for a new generation of targeted cancer diagnostics and therapies. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in … Type: | 1 | 0 | 1 | 445 |
 | Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: | 3 | 2 | 2 | 39 |
 | VarmX VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in … Type: | 0 | 0 | 0 | 26 |
 | MoonLake Immunotherapeutics (NASDAQ: MLTX) Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17 | 3 | 1 | 2 | 86 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 1 | 0 | 0 | 5 |
 | MolDrug Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug (a ProtoQSAR company) is a group specializing in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, … Type: | 0 | 0 | 0 | 3 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … Type: | 11 | 0 | 9 | 73 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 1 | 1 | 0 | 72 |
 | Deep Lens (acquired by Paradigm) Accelerating clinical trial matching in oncology Deep Lens is a digital healthcare company focused on enabling faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis using VIPER. Deep Lens’ AI-driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials and the ability to collaborate on groundbreaking cancer research across all cancer types. Artificial Intelligence, Pharmaceuticals , Cancer Research, Oncology, and Pathology Type: | 6 | 1 | 3 | 5 |
 | Olaris, Inc Removing the Guesswork from Medicine Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARISTM diagnostics products, which aim to optimize treatments and outcomes for individual patients. Metabolite diagnostics empower therapeutic selection, treatment effectiveness monitoring, disease diagnosis, and target identification across indications and therapeutics areas, including oncology, solid-organ transplant, and neurodegeneration. Our mission is to remove the guesswork from medicine. Diagnostics, Machine Learning, Metabolomics, NMR, Mass Spectrometry, Statistics, Transplant, and Oncology Type: | 1 | 1 | 1 | 14 |
 | Murrieta Genomics Launching the Next Great Genomic Startups Murrieta Genomics is dedicated to advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise. We are a true incubator, offering dedicated bench space to fledgling companies at basically zero cost, helping them to define their business model and validate their science, and then investing in the companies that “graduate” the incubator. We are located in the 16,000 square foot Murrieta Innovation Center in Southern California, in close proximity … | 1 | 1 | 0 | 8 |
 | Circuit Clinical An IRO committed to better access to clinical research, the development of new medicines, and health equity. Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site … Type: | 10 | 1 | 6 | 101 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 1 | 0 | 0 | 28 |
 | Perpetual Biotechnologies Founded in 2015, as a renewable clean technology company, our mission is to develop sustainable algae derived products and ideas that will embrace the nature and help humanity. Algae, Nutraceuticals, Cosmetics, Pharmaceuticals, and Cleantech Type: | 0 | 0 | 0 | 2 |
 | AccuHealth [Automatic translation follows] Together in the control of your health We are the first Telehealth company in Chile and South America. Our Virtual Clinical Hospital is dedicated to providing continuity of care and remote care, with an emphasis on prevention and close monitoring of patients through our Telemonitoring service, who are accompanied and guided, 24 hours a day, by a team of highly trained professionals in their areas of work. Our business model adapts to the specific needs of each institution, making us an ally and strategic complement for doctors, insurers and health providers, delivering an innovative service with high … Type: | 1 | 0 | 0 | 19 |
 | LONO Côte d'Ivoire Transformez vos sous-produits en revenus supplémentaires LONO is a biotechnology company in Côte d'Ivoire, converting organic waste into electricity and fertilizer. Agriculture, Biotechnology, and Sustainability Type: | 4 | 1 | 4 | 15 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 41 | 16 | 33 | 70 |
 | PB&B Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … Type: | 0 | 0 | 0 | 4 |
 | SOPHiA GENETICS Democratizing Data-Driven Medicine, Together! SOPHiA GENETICS is the creator of SOPHiA DDMTM, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different modalities. The SOPHiA DDMTM Platform enables healthcare institutions to get quick, robust insights from their data. We apply our technology to areas such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support research and drug development efforts. SOPHiA GENETICS' data-sharing methodology also helps researchers and healthcare professionals work together as a community by sharing and leveraging patterns identified via artificial intelligence and machine learning. Our … Type: | 33 | 19 | 13 | 486 |
 | SwissDeCode Real-time food quality, authentication and compliance for farmers, food manufacturers and food authorities. SwissDeCode helps farmers and food manufacturers to grow and produce high quality products by offering a variety of rapid, on-site DNA testing solutions. We help brands launch new premium products faster and companies to transition to more sustainable value chain practices. Get in touch to discuss your testing needs. Food Authentication, Supply Chain Traceability, DNA Testing, Sustainable Operations, Food Compliance, Right First Time, Undeclared ingredients, Antimicrobial Resistance, Product Recalls, Process improvement, Food DNA, Food Defense, Supplier specifications, Evidence of origin, A2 milk, and Cocoa Swollen Shoot Virus Type: | 11 | 4 | 7 | 10 |
 | Molecule AG A decentralised biotech protocol porting intellectual property into web3 and launching biotech DAOs We propel science from lab to life, fueled by a community committed to human progress. blockchain, pharma, health, science, biotech, and Token Bonding Curves Type: | 12 | 0 | 9 | 38 |
 | Modum From Finished Product to Consumer - Creating Trusted Digital Ecosystems for Sensitive Goods Data integrity for supply chain operations, powered by cutting-edge blockchain & IoT technology. Modum offers a digital supply chain monitoring & optimization solution that measures environmental conditions at high shipment volumes for the pharma industry. Our first solution enables pharma distributors to fulfil regulatory obligations under GDP in an efficient and cost effective way. Modum is currently in collaboration with Swiss Post and SAP. Our first solution allows for user-friendly deviation management in a web application. It offers instant notifications of temperature excursions and other events, such … Type: | 13 | 1 | 8 | 7 |
 |  Polyneuron Pharmaceuticals AG Precision treatment of immune disorders Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-CatchTM technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients. Type: | 2 | 1 | 0 | 4 |
 | Vicept Therapeutics, Inc Start-up Dermatology Company. Type: | 13 | 1 | 0 | 1 |
 | Quantgene We bring life-saving genomics to hospitals, physicians and patients everywhere. Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 4 | 0 | 4 | 39 |
 | Gaskiya Diagnostics Rapid, low-cost, easy-to-use diagnostic tests for aquaculture. We develop ultra-low cost, paper-based rapid diagnostic test kits with equipment-free results. | 1 | 1 | 1 | 4 |
 | VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | Livinguard Technologies AG Enhancing the functionality & performance of materials across various applications through the power of surface charge. Livinguard Technologies is a Swiss material science company focused on enhancing the functionality & performance of materials across various applications through the power of surface charge. Our mission is to safeguard the wellbeing of people and the environment with our high performance, sustainable technology platform. Understanding that we have one planet with limited resources has shaped our approach to innovation. We help our partners change consumption patterns and processing parameters to limit the generation of waste and use of resources while maintaining highest standards … Type: | 3 | 0 | 2 | 12 |
 | eXmoor Pharma eXmoor is a full service Cell & Gene Therapy CDMO, backed by over 20 years manufacturing experience for 150+ clients eXmoor is a full service Cell & Gene Therapy CDMO with a difference. We are backed by 20 years consultancy experience supporting over 150 organisations accelerate novel therapies from discovery to patients. We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release. We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the … Type: | 1 | 0 | 1 | 78 |
 | Valence Labs Industrializing scientific discovery to radically improve lives. Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) in May 2023, Valence Labs continues as a semi-autonomous AI research engine within Recursion aiming to advance the frontier of deep learning in drug discovery. Valence Labs operates with the unique combination of the intellectual freedom of academia but the resources and stability of industry. Valence Labs is headquartered in … Type: | 12 | 1 | 9 | 50 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 3 | 0 | 3 | 18 |
 | BÜHLMANN Laboratories AG BÜHLMANN is a fully independent, medium sized and family owned Swiss company. Founded in 1976, BÜHLMANN today has local teams in Switzerland, France, Italy, Germany, Austria, USA and Brazil and distributors worldwide. BÜHLMANN has become the prime calprotectin company within few years, offering the broadest range of calprotectin assays from fully automatable, high-throughput turbidimetric and ELISA assays, BÜHLMANN fCAL® turbo and BÜHLMANN fCAL® ELISA, to the point-of-care quantitative Quantum Blue® and IBDoc® home test application. Additional to calprotectin assays, BÜHLMANN offers therapeutic drug monitioring solutions for biologics used in chronic inflammatory diseases. BÜHLMANN does not only stand for calprotectin, but … Type: | 0 | 0 | 0 | 114 |
 | Diatech Pharmacogenetics Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine. Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions … Type: | 3 | 1 | 1 | 62 |
 | Sus Clinicals, Inc. Enabling our healthcare client partners to accelerate breakthrough cancer solutions. Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies. Type: | 0 | 0 | 0 | 17 |
 | ELIAS Animal Health Changing the way cancer is fundamentally treated. ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Our approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. The ELIAS Cancer Immunotherapy (ECI®) works by conditioning the immune system to recognize a patient’s unique cancer, and then delivering an army of activated killer T cells to specifically target and attack those cancer cells. Learn more at eliasanimalhealth.com. Type: | 0 | 0 | 0 | 10 |
 | ImpriMed, Inc. AI-driven Personalized Medicine for Cancer Care ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 17,000+ canine and feline blood cancer tests have been performed as of 2024. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional … Type: | 0 | 0 | 0 | 38 |
 | Loyal Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs. Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to … Type: | 0 | 0 | 0 | 201 |
 | Burdock Group Consultants fusing science & compliance Burdock Group is an international safety and regulatory consultancy that helps clients with solutions for their compliance needs. Our experienced staff of project managers, scientists and toxicologists provides unparalleled expertise in food, beverage, dietary supplements, pet food, animal feed, Hemp/CBD, EPA, cosmetics and personal care products. With over 30 years of documented experience and frequent publications on current scientific and regulatory issues, Burdock Group has been recognized worldwide as the industry leader. We provide reliable, timely, and cost-effective support to help you navigate the challenges associated with achieving regulatory compliance when entering new markets, introducing new … | 1 | 0 | 1 | 12 |
 | Microbiologics The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug … Type: | 1 | 0 | 2 | 351 |
 | Families Fighting Flu A nonprofit advocacy organization dedicated to protecting people from the devastating effects of flu. Families Fighting Flu is more than just a name – it’s who we are and what we do. We are a nonprofit advocacy organization dedicated to protecting children, families, and communities against the flu. health education, public health, vaccines, flu vaccine, health promotion, health communication, advocacy, vaccination, flu, immunization, healthcare, and awareness Type: | 5 | 2 | 4 | 7 |
 | Pinney Associates, Inc. Guiding Pharmaceutical and Consumer Healthcare Companies to Success Pharmaceutical and consumer healthcare companies work within dynamic, sometimes unpredictable, regulatory and commercial environments. Pinney Associates' multidisciplinary teams anticipate your scientific and policy obstacles while guiding you toward regulatory and marketplace success. Pharmaceuticals, Risk Management, Abuse Liability Testing, Rx to OTC Switch, In vitro, Abuse potential assessment, Consumer healthcare, Consumer insights, Business development, FDA, CNS active drugs, Regulatory, Over-the-counter medicines, OTCs, Nonprescription drugs, Dietary supplements, Regulatory Strategy, Clinical Development, Eight Factor Analysis 8FA, Abuse Deterrent Formulation Evaluation, Postmarketing Surveillance, Risk Evaluation and Mitigation Strategies, REMS, Target Product Profiles, Scientific Assessment and Review, … Type: | 4 | 0 | 4 | 28 |
 | RTI Health Solutions Providing the trusted research and strategic planning services you need for your drug or medical device. RTI Health Solutions' integrated project teams are here to help you with your pharmaceutical and medical device research needs. Our robust and trusted methods provide answers to the research questions relevant to your drug or device. Our experienced teams are with you throughout your product's lifecycle to ensure you have the evidence you need when you need it. They continuously monitor your portfolio of projects to keep them flowing seamlessly—enabling you to focus your time elsewhere. Follow us @RTIHS on Twitter too. We are … Type: | 2 | 0 | 2 | 369 |
 | electroCore, Inc. In 2005, we were founded on a unified belief that neuromodulation could be used in novel ways to help patients break free from treatments they aren’t happy with. Because different modalities of neuromodulation had previously proven to be effective and safe, we recognized an opportunity to be the leader in this new frontier of medicine and took it head on. Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments. Bringing new treatments to market … Type: | 3 | 1 | 1 | 83 |
 | Ra Medical Systems Our Mission: Save lives, limbs and improve patients’ quality of life. Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases. Pharos excimer laser system was launched in October 2004 and was used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. The company sold these dermatological products and services in August 2021 to focus solely on the larger vascular business opportunity. In May 2017, the DABRA laser and single-use catheter (together “DABRA”) received FDA 510(k) clearance in the U.S. for crossing … Type: | 2 | 2 | 0 | 38 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … Type: | 4 | 1 | 2 | 141 |
 | Jamie's Farm Farming, Family, Therapy, Legacy - a charity helping vulnerable young people at risk of social and academic exclusion. Jamie’s Farm acts as a catalyst for change, enabling young people to thrive academically, socially and emotionally. We do this through a unique residential experience and rigorous follow-up programme, combining ‘family, farming, therapy and legacy'. To date, we have worked with over 6,000 young people and demonstrated significant improvements in self-esteem, engagement and behaviour, in addition to softer skills such as resilience, grit and motivation. We are also having a positive impact on the way educational professionals work with young people displaying … Type: | 1 | 1 | 2 | 37 |
 | Branch Out Neurological Foundation Accelerating neuroscience for brains at their best! Branch Out accelerates tech solutions and non-pharmaceutical approaches to neurological conditions. Through our grant program, we fund top neuroscientists exploring alternative brain research. Our vision? Accelerating neuroscience for brains at their best! We fund research that fits into the rigorous NeuroCAM (Neuroscience + Complementary & Alternative Modalities) criteria. All research proposals are reviewed by our Scientific Review Panel to ensure it meets the highest quality of research methods and scientific measures. Since 2010, we’ve raised over $3.5 million for alternative brain research, funded over 110 research projects, and have expanded our University Grant … Type: | 2 | 1 | 1 | 6 |
NGO, Think-tanks, Ed, & Culture